2017 House Bill 4472 / 2018 Public Act 41

Show analysis

Introduced in the House

March 30, 2017

Introduced by Rep. John Bizon (R-62)

To allow pharmacists to dispense FDA-designated interchangeable biological drug products.

Referred to the Committee on Health Policy

Jan. 17, 2018

Reported without amendment

With the recommendation that the substitute (H-3) be adopted and that the bill then pass.

Jan. 24, 2018

Amendment offered by Rep. Hank Vaupel (R-47)

The amendment passed by voice vote

Jan. 25, 2018

Passed in the House 105 to 1 (details)

Received in the Senate

Jan. 30, 2018

Referred to the Committee on Health Policy

Jan. 31, 2018

Reported without amendment

With the recommendation that the bill pass.

Feb. 15, 2018

Passed in the Senate 34 to 0 (details)

To allow pharmacists to dispense FDA-designated interchangeable biological drug products.

Signed by Gov. Rick Snyder

Feb. 28, 2018